Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
-
* Corresponding author: Abdinasir A Amin aamin@wtnairobi.mimcom.net
Malaria Journal 2005, 4:36 doi:10.1186/1475-2875-4-36
Accesses
- Last 30 days: 130 accesses
- Last year: 780 accesses
- All time: 5966 accesses
Cited by
BioMed Central: 6 citations
|
Research
Kathryn A O'Connell, Hellen Gatakaa, Stephen Poyer, Julius Njogu, Illah Evance, Erik Munroe, Tsione Solomon, Catherine Goodman, Kara Hanson, Cyprien Zinsou, Louis Akulayi, Jacky Raharinjatovo, Ekundayo Arogundade, Peter Buyungo, Felton Mpasela, Chérifatou Adjibabi, Jean Agbango, Benjamin Ramarosandratana, Babajide Coker, Denis Rubahika, Busiku Hamainza, Steven Chapman, Tanya Shewchuk, Desmond Chavasse Malaria Journal 2011, 10:326 (31 October 2011) This article is part of a collection on The ACTwatch project:... Useful synthesis of survey results providing essential information on the availability of anti-malarials, especially in the private sector where data has been extremely limited.
|
|
Research
Barriers to prompt and effective malaria treatment among the poorest population in Kenya Jane Chuma, Vincent Okungu, Catherine Molyneux Malaria Journal 2010, 9:144 (27 May 2010) Evidence suggests that the poorest populations benefit less from malaria control interventions, and are less likely to seek prompt and effective treatment.
|
|
Research
Edith Patouillard, Kara G Hanson, Catherine A Goodman Malaria Journal 2010, 9:50 (11 February 2010) A valuable and timely analysis of all the existing literature on the topic: with the advent of AMFm, it addresses the very important issue of private supply chain for anti-malarials.There needs to be nationally representative work done on this topic and more research into pricing determinants.
|
|
Review
Jane Chuma, Timothy Abuya, Dorothy Memusi, Elizabeth Juma, Willis Akhwale, Janet Ntwiga, Andrew Nyandigisi, Gladys Tetteh, Rima Shretta, Abdinasir Amin Malaria Journal 2009, 8:243 (28 October 2009) This review on access to malaria treatment in Kenya is particularly interesting in the light of the wealth of studies that have been carried out on related topics in Kenya.
|
|
Research
Sivong Sengaloundeth, Michael D Green, Facundo M Fernández, Ot Manolin, Khamlieng Phommavong, Vongsavanh Insixiengmay, Christina Y Hampton, Leonard Nyadong, Dallas C Mildenhall, Dana Hostetler, Lamphet Khounsaknalath, Latsamy Vongsack, Samlane Phompida, Viengxay Vanisaveth, Lamphone Syhakhang, Paul N Newton Malaria Journal 2009, 8:172 (28 July 2009) An original and interesting piece of work that attempts to fill a gap in knowledge with regards to both research methodology in counterfeit drugs and the problem of artemisinin monotherapy. The results are very concerning and have important policy implications.
|
|
Research
Chloroquine resistance before and after its withdrawal in Kenya Leah Mwai, Edwin Ochong, Abdi Abdirahman, Steven M Kiara, Steve Ward, Gilbert Kokwaro, Philip Sasi, Kevin Marsh, Steffen Borrmann, Margaret Mackinnon, Alexis Nzila Malaria Journal 2009, 8:106 (18 May 2009) Description of a longitudinal study of the prevalence of alleles of P. falciparum that associated with resistance to chloroquine and pyrimethamine in Kilifi, Kenya between 1993 and 2006. This data set was used to calculate the selection coefficient and infer the apparent fitness of the different alleles. This is a salutary reminder that the control of anti-malarial drug use is loose in most settings and the impact of official changes in policy is complex and unpredictable.
|